GGrantIndex
← Leaderboards

J. David Gladstone Institutes

San Francisco, CA

Compare ↔
$772,623,776
Total funding
479
Grants

Funding over time

peak $53M · FY2005–25
$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$772,623,776 · 479

By mechanism

R01$322,308,426 · 148
P01$107,223,118 · 88
U01$82,850,768 · 13
RF1$57,955,480 · 17
UM1$34,536,035 · 3
DP1$25,881,338 · 6

Investigators at J. David Gladstone Institutes

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Michael Alexanian$1,615,6532 gr2Laura Parkkinen$1,049,3412 gr3Andrew S Mendiola$984,6752 gr4Ashley F George$747,0001 gr5Julia Ann Kaye$728,4081 gr

Emerging Leaders

6–10 yrs in

1Misha Yuri Zilberter$5,454,7204 gr2Kole T Roybal$3,071,9753 gr3Mark A Petersen$1,472,2011 gr4Seth Lawler Shipman$1,313,5272 gr5Keran Ma$742,0021 gr6Sudha Krishnamurthy$267,3001 gr7Lyandysha Viktorovna Zholudeva$35,0002 gr

All-Time

Most funded here, all years

1Steven M Finkbeiner$40,981,27422 gr2Eric M Verdin$40,409,07713 gr3Yadong Huang$35,541,63318 gr4Melanie Maria Ott$33,068,42722 gr5Deepak Srivastava$29,064,4019 gr6Douglas F Nixon$27,911,10921 gr7Stephen G Young$24,141,18012 gr8Bruce R Conklin$22,892,47811 gr

Largest grants

Chemoprophylaxis for HIV Prevention in Men$15,906,431
U01 · FY2010 · AI
Chemoprophylaxis for HIV Prevention in Men$7,860,058
U01 · FY2009 · AI
HOPE - HIV Obstruction by Programmed Epigenetics$6,334,269
UM1 · FY2023 · AI
Vascular-immune mechanisms of cerebral amyloid angiopathy and Alzheimer's pathology$5,423,836
RF1 · FY2024 · NS
HOPE - HIV Obstruction by Programmed Epigenetics$5,336,026
UM1 · FY2024 · AI
HOPE - HIV Obstruction by Programmed Epigenetics$5,336,026
UM1 · FY2022 · AI
HOPE - HIV Obstruction by Programmed Epigenetics$5,336,026
UM1 · FY2021 · AI
Chemoprophylaxis for HIV Prevention in Men$5,141,967
U01 · FY2008 · AI
HOPE - HIV Obstruction by Programmed Epigenetics$4,951,244
UM1 · FY2025 · AI
Proteomic and Genetic Approaches Defining Apolipoprotein E4 Neuropathologic Mechanisms$4,669,193
RF1 · FY2019 · AG
Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease$4,657,774
P01 · FY2024 · AG
Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease$4,657,222
P01 · FY2023 · AG
Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease$4,626,857
P01 · FY2021 · AG
Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease$4,611,009
P01 · FY2022 · AG
Decoding the Multifactorial Etiology of Neural Network Dysfunction in Alzheimer's Disease$4,564,091
P01 · FY2025 · AG
Neural network and immune cell dysfunctions in Alzheimer's disease pathogenesis$4,538,275
RF1 · FY2019 · AG
Fibrinogen and vascular cognitive impairment: mechanisms, imaging, therapeutics$4,523,685
RF1 · FY2019 · AG
Chemoprophylaxis for HIV Prevention in Men$4,388,511
U01 · FY2011 · AI
Proteinopathies of the Aging Central Nervous System$3,948,699
P01 · FY2011 · AG
Contribution of DNA Repair Deficits to Alzheimer Pathogenesis$3,714,865
RF1 · FY2016 · AG